Search Results - "Ansell, J E"

Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management by Ansell, Jack E., Hughes, Robert

Get full text

Empowering Patients to Monitor and Manage Oral Anticoagulation Therapy by Ansell, Jack E

“…An editorial discusses Sawicki et al's description of a model of anticoagulation management that introduces patient self-management made possible by…”
Get full text

Imprecision of prothrombin time monitoring of oral anticoagulation. A survey of hospital laboratories by Ansell, J E

“…Prothrombin time monitoring of oral anticoagulation is highly dependent on the tissue thromboplastin used. In the United States, patients have received a…”
Get more information

The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study by Vander Salm, T J, Ansell, J E, Okike, O N, Marsicano, T H, Lew, R, Stephenson, W P, Rooney, K

“…Sixty patients scheduled for elective coronary artery bypass graft operations were randomly assigned to receive epsilon-aminocaproic acid or placebo to test…”
Get more information

Heparin-induced thrombocytopenia. What is its real frequency? by Ansell, J E, Price, J M, Shah, S, Beckner, R R

“…A prospective study of 104 patients was undertaken to determine the frequency of severe heparin-induced thrombocytopenia in patients receiving either bovine…”
Get more information

Coagulation abnormalities associated with the use of anabolic steroids by Ansell, J E, Tiarks, C, Fairchild, V K

“…According to a number of recent reports, persons using anabolic steroids may be subject to an increased risk of thromboembolism. We evaluated the effect of…”
Get more information

Air Travel and Venous Thromboembolism — Is the Evidence In? by Ansell, Jack E

“…Long Flights Can Cause Blood Clots, Group Warns — Boston Globe, August 30, 1997 Airlines Sued over Blood Clots — The Times, London, January 8, 2001…”
Get full text

The quality of anticoagulation management by Ansell, J E

Get more information

Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times by Ansell, J E, Hamke, A K, Holden, A, Knapic, N

“…The authors assessed the cost effectiveness of monitoring warfarin therapy guided by standard plasma prothrombin times performed on blood samples obtained by…”
Get more information

Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Evidence of a separate stem cell origin by Maher, V E, Gill, L, Townes, P L, Wallace, J E, Savas, L, Woda, B A, Ansell, J E

“…The authors studied a patient with the simultaneous occurrence of chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML). The coexistence of…”
Get more information

Vitamin B12 levels and age by Hitzhusen, J C, Taplin, M E, Stephenson, W P, Ansell, J E

“…Vitamin B12 concentration was determined by radioassay in 179 healthy volunteers between the ages of 20 and 93 years in order to determine whether vitamin B12…”
Get more information

Hypercoagulability: a conceptual and diagnostic approach by Ansell, J E

Get more information

Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi by Hnatowich, D J, Virzi, F, Doherty, P W, Wilson, J, Rosa, J, Ansell, J E

“…The in vitro functional properties of recombinant tissue plasminogen activator (rt-PA), its biodistribution in mice, and its pharmacokinetics and clot…”
Get full text

Control of bleeding varices by vasopressin: a prospective randomized study by Johnson, W C, Widrich, W C, Ansell, J E, Robbins, A H, Nabseth, D C

“…From July 1975 to November 1976 25 patients with bleeding esophagogastric varices documented by endoscopy who failed to respond to conservative medical…”
Get full text

Oral anticoagulants for the treatment of venous thromboembolism by Ansell, J E

“…Oral anticoagulation has been the mainstay of therapy for the long-term treatment of venous thromboembolism since the 1940s. The rationale for the use of oral…”
Get full text

Clinical trial of a new bleeding-time device by Kumar, R, Ansell, J E, Canoso, R T, Deykin, D

“…The authors report a clinical trial comparing a new bleeding time device (Simplate II) with the Mielke Template. Bleeding times were determined at the same…”
Get more information

Oral anticoagulant therapy--50 years later by Ansell, J E

“…The year 1991 marked the 50th anniversary of the first clinical use of oral anticoagulant therapy as a means of preventing thromboembolic disease. Despite…”
Get more information

In vivo survival of red blood cells processed by a bubble or membrane oxygenator during cardiopulmonary bypass surgery by ANSELL, J. E, VANDERSALM, T, STEPHENSON, W, SZYMANSKI, I, FOURNIER, L

“…A dual radioisotope labeling technique was utilized to assess red cell survival differences between cells processed by either a bubble oxygenator (eight…”
Get full text

Platelet-aggregating factor in thrombotic thrombopenic purpura plasma [letter] by Ansell, Jack E, Slepchuk, Nicholas I, Pechet, Liberto

Get full text

Oral anticoagulant drugs by Ansell, J E

Get full text